FluoRok founder and CEO Gabriele Pupo (seated, center) with members of the company’s leadership team Credit: FluoRok The ...
In a first-in-human trial, researchers found that chemogenetic therapy appears safe in several people with epilepsy ...
With Democrats winning control of Congress, researchers aim to reverse budget cuts, block political interference, and rebuild ...
New analytical technique may enable continent to monitor industrial toxic emissions more easily and quickly ...
Reducing the expression of MSH3 in neurons could slow expansion of CAG repeats in the huntingtin gene ...
Emails obtained by the Environmental Defense Fund show collaboration on exemptions granted to chemical and other industrial ...
Scientific questions about the popular botanical extract and its synthetic analogs abound. New rules may make them harder to ...
The new software, AI Link, connects large language models to laboratory software so that scientists can request broad tasks ...
Chemistry needs a voice in the policy conversation, and I want to ensure that as many of those voices as possible are ours.
The Swiss contract development and manufacturing organization (CDMO) Lonza has agreed to buy the drug services business of ...
Simulations suggest that few cometary impacts could have delivered enough hydrogen cyanide to support the chemistry that ...
From these new findings, “we know chemically it’s got a lot of phosphorus, it’s got a lot of iron, it’s elevated in chlorine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results